Literature DB >> 16377284

Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.

Francisco Marín1, Domingo A Pascual, Vanessa Roldán, José María Arribas, Miguel Ahumada, Pedro Luis Tornel, Clara Oliver, Jesús Gómez-Plana, Gregory Y H Lip, Mariano Valdés.   

Abstract

Atrial fibrillation (AF) is a common complication after coronary artery bypass grafting. Atrial remodeling has been observed in AF and has been associated with the development of this arrhythmia. Because 3-hydroxy-3-methylglutaryl coenzyme A inhibitors (statins) have been demonstrated to modify remodeling, we hypothesized a protective role of statins against postoperative AF. We also hypothesized that extracellular matrix turnover and brain natriuretic peptide (BNP) might be related to such atrial remodeling. We studied 234 consecutive patients who underwent coronary artery bypass grafting (173 men; 65 +/- 9 years of age) in whom the occurrence of postoperative AF was monitored. In a subgroup of 66 patients, we measured plasma levels of matrix metalloproteinase-1 (MMP-1), its inhibitor, tissue inhibitor matrix metalloproteinase-1 (TIMP-1; as indexes of extracellular matrix remodeling), and N-terminus pro-BNP (related to left ventricular function) at baseline and at 24 hours after surgery. Of 234 patients, 66 (28.2%) developed postoperative AF. In multivariate analysis, previous AF was related to an increase in the development of AF (odds ratio 11.92, 95% confidence interval 2.37 to 59.98, p = 0.026), whereas statin use was related to a decrease in arrhythmia (odds ratio 0.52, 95% confidence interval 0.28 to 0.96, p = 0.038). A higher TIMP-1/MMP-1 ratio at 24 hours after surgery was present in those who did not develop postoperative AF (p = 0.043). Statin use was associated with increased TIMP-1 levels and TIMP-1/MMP-1 ratio (p = 0.027 and 0.036, respectively). No significant relations to N-terminus pro-BNP were seen. In conclusion, previous AF and nonuse of statins are significantly associated with AF after coronary artery bypass grafting. Statin use may be protective against AF after coronary artery bypass grafting, possibly due to alterations in the extracellular matrix and remodeling after coronary artery bypass grafting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377284     DOI: 10.1016/j.amjcard.2005.07.124

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

Review 1.  Statin therapy in cardiovascular diseases other than atherosclerosis.

Authors:  Dominique Beaudry; Kenneth E Stone; Suzanne Wetherold; John Hemphill; Dat Do; John McClish; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

2.  Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation.

Authors:  Kiyoshi Tamura; Hirokuni Arai; Fusahiko Ito; Takeshi Someya; Tomohiro Ushiyama; Naoto Miyagi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-03-11

Review 3.  The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.

Authors:  Wen-tong Fang; Hong-Jian Li; Haibo Zhang; Su Jiang
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

4.  Effect of Statins in Preventing Postoperative Atrial Fibrillation Following Cardiac Surgery.

Authors:  Liang Yin; Zhinong Wang; Yifeng Wang; Guangyu Ji; Zhiyun Xu
Journal:  J Atr Fibrillation       Date:  2010-03-01

5.  Do Statins Reduce Atrial Fibrillation After Coronary Artery Bypass Grafting?

Authors:  Anil Paturi; Aman Shukla; George Ebra; Viet Nguyen; Steven Borzak
Journal:  J Atr Fibrillation       Date:  2011-07-15

6.  Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial.

Authors:  C N Pellegrini; E Vittinghoff; F Lin; S B Hulley; G M Marcus
Journal:  Heart       Date:  2009-01-28       Impact factor: 5.994

7.  Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery.

Authors:  Gregory A Fleming; Katherine T Murray; Chang Yu; John G Byrne; James P Greelish; Michael R Petracek; Steven J Hoff; Stephen K Ball; Nancy J Brown; Mias Pretorius
Journal:  Circulation       Date:  2008-09-29       Impact factor: 29.690

Review 8.  Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

Authors:  Hadi Ar Hadi; Wael Al Mahmeed; Jassim Al Suwaidi; Samer Ellahham
Journal:  Vasc Health Risk Manag       Date:  2009-06-29

9.  Oxidative stress markers are associated with persistent atrial fibrillation.

Authors:  Robert B Neuman; Heather L Bloom; Irfan Shukrullah; Lyndsey A Darrow; David Kleinbaum; Dean P Jones; Samuel C Dudley
Journal:  Clin Chem       Date:  2007-06-28       Impact factor: 8.327

10.  Dose dependent effect of statins on postoperative atrial fibrillation after cardiac surgery among patients treated with beta blockers.

Authors:  Salima Mithani; Muhammad S Akbar; Deborah J Johnson; Michael Kuskowski; Katherine K Apple; Jana Bonawitz-Conlin; Herbert B Ward; Rosemary F Kelly; Edward O McFalls; Hanna E Bloomfield; Jian-Ming Li; Selcuk Adabag
Journal:  J Cardiothorac Surg       Date:  2009-11-04       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.